Download Citation
Article Source:
Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV
Peltenburg NC,
Bierau J,
Bakker JA,
Schippers JA,
Lowe SH,
et al.
(2018)
Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV.
PLOS ONE 13(1): e0191069.
https://doi.org/10.1371/journal.pone.0191069